This fact sheet provides a snapshot of global malaria efforts and examines the U.S. government’s role in addressing malaria worldwide, including current programs, funding, and key issues.
- view as grid
- view as list
This fact sheet looks at the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global initiative to combat HIV/AIDS.
The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis (TB); malaria/the President’s Malaria Initiative (PMI); the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health (MCH); nutrition; family planning & reproductive health (FP/RH); global health security; and neglected tropical diseases (NTDs).
This updated fact sheet examines the key role played by the United States in the Global Fund, an independent, multilateral financing entity designed to raise significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.
The G20 and development assistance for health: historical trends and crucial questions to inform a new era
In this article for The Lancet, KFF’s Jennifer Kates and 19 co-authors examine trends in the provision and receipt of development assistance for health (DAH), particularly for the G20 countries. The article looks at key questions facing leaders of the G20 countries, including how to best focus DAH for equitable health gains, how to deliver DAH to strengthen health systems, and how to support domestic resource mobilization and tranformative partnerships for sustainable impact.
On Thursday, April 25, the Kaiser Family Foundation and the CSIS Global Health Policy Center held a policy roundtable on the latest data on funding for global health, including from the U.S. government. It began with a brief presentation by Joseph Dieleman of the Institute for Health Metrics and Evaluation…
This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.
In this Policy Insight, Jen Kates and Josh Michaud look at the prospects for the future of U.S. global health policy, examining whether long-term bipartisan support may be tested during a time of political transition, and identifying key areas of consensus among policymakers and the public.
After Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.
This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2016 Budget Request released on February 2, 2015.